Extendicare Inc.
CA$26.76+CA$0.46 (+1.75%)
Extendicare Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.63% below the high.
TSX · CRON.TO · CAD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Cronos Group Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.21% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Cronos Group Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of CA$0.04. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Cronos Group Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under its Lord Jones and Happy Dance brands through online sales, traditional retail, and hospitality partner networks. The company also plays a significant role in the cultivation, production, and commercialization of cannabis and cannabis-infused products for both medicinal and adult-use sectors. Its comprehensive product offerings encompass dried cannabis flower, pre-rolled joints, edibles, concentrated forms, and cannabis extracts. These are distributed via wholesale partnerships and direct-to-consumer channels, prominently featuring its wellness platform, PEACE NATURALS, and its adult-use brand, Spinach. Moreover, Cronos Group exports dried cannabis and cannabis oils to international markets including Germany, Israel, and Australia. Established in 2012, the company maintains its corporate headquarters in Toronto, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 8, 2025 | CA$0.03+99.58% vs estimate | CA$48.39M+6.0% vs estimate |
|---|
| Q4 2024 | Feb 27, 2025 | CA$0.16+3,394.48% vs estimate | CA$43.93M-12.55% vs estimate |
|---|
| Q3 2024 | Nov 12, 2024 | CA$0.02+300.0% vs estimate | CA$46.36M+11.97% vs estimate |
|---|
THE ANALYST VIEW
12 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$26.76+CA$0.46 (+1.75%)
Extendicare Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.63% below the high.
$10.60-$0.02 (-0.19%)
Trulieve Cannabis Corp.’s quoted price sits in the upper half of its reported 52-week range, 20.18% below the high.
CA$19.92+CA$0.06 (+0.3%)
Sienna Senior Living Inc.’s quoted price sits in the lower half of its reported 52-week range, 17.24% below the high.
$6.43+$0.02 (+0.31%)
Green Thumb Industries Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.35% below the high.
CA$11.40+CA$0.09 (+0.8%)
Knight Therapeutics Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.63% below the high.
CA$4.20+CA$0.06 (+1.45%)
WELL Health Technologies Corp.’s quoted price sits in the lower half of its reported 52-week range, 21.05% below the high.
CA$3.68-CA$0.06 (-1.6%)
Tilray Brands, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.94% below the high.
CA$7.28+CA$0.16 (+2.25%)
Verano Holdings Corp’s quoted price sits in the lower half of its reported 52-week range, 45.26% below the high.